Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Universidade de Vigo | Spain

Dr. Lorena García Hevia is a distinguished researcher recognized for her pioneering work at the intersection of nanomedicine, microbiology, and biotechnology. As a member of the Hybrid Nanomaterials Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur), she has dedicated her career to advancing innovative nanotechnological solutions that address critical biomedical challenges. Her research focuses primarily on the design and application of nanoscale systems to improve therapeutic delivery, particularly within the context of infectious disease management and antimicrobial resistance.Affiliated with the CINBIO (Biomedical Research Center) and the Universidade de Vigo in Spain, Dr. García Hevia brings an interdisciplinary approach that bridges biochemical, genetic, and immunological insights with advanced materials science. Her scientific vision emphasizes the development of intelligent nanocarriers that enhance drug stability, optimize bioavailability, and enable targeted therapy. Through this approach, she contributes to transforming conventional treatments into highly efficient, patient-specific solutions.In her recent publication Nanomedicine for Phage Therapy: Encapsulation Strategies for Enhanced Antimicrobial Efficacy, Dr. García Hevia and her colleagues explore the integration of nanotechnology with bacteriophage therapy to overcome limitations in traditional antimicrobial strategies. Her work demonstrates how encapsulation methods—such as polymeric nanoparticles, liposomes, hydrogels, and nanofibers—can significantly improve the stability, delivery, and therapeutic impact of bacteriophages. These innovative formulations facilitate localized and sustained release, providing powerful alternatives against multidrug-resistant infections.Dr. García Hevia’s research is marked by creativity, precision, and translational relevance. Her investigations into responsive nanocarriers and inorganic nanoparticles have opened new avenues for targeted phage delivery, aligning with global efforts to combat antibiotic resistance through sustainable and effective biotechnological interventions. Beyond her scientific achievements, she is deeply engaged in academic mentorship and collaborative research initiatives that strengthen the connection between laboratory innovation and clinical application.Her contributions continue to shape the evolving field of nanomedicine, positioning her as a leading figure in the development of next-generation antimicrobial therapies. Through her commitment to excellence and scientific innovation, Dr. Lorena García Hevia exemplifies the transformative potential of nanotechnology in redefining the future of infection control and precision therapeutics.

Profile: Google Scholar

Featured Publications

García‐Hevia, L., Bañobre‐López, M., & Gallo, J. (2019). Recent progress on manganese‐based nanostructures as responsive MRI contrast agents. Chemistry–A European Journal, 25(2), 431–441.

García-Hevia, L., Valiente, R., Martín-Rodríguez, R., Renero-Lecuna, C., et al. (2016). Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 8(21), 10963–10973.

Rodrigues, R. O., Baldi, G., Doumett, S., García-Hevia, L., Gallo, J., et al. (2018). Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery. Materials Science and Engineering: C, 93, 206–217.

García‐Hevia, L., Villegas, J. C., Fernández, F., Casafont, Í., González, J., et al. (2016). Multiwalled carbon nanotubes inhibit tumor progression in a mouse model. Advanced Healthcare Materials, 5(9), 1080–1087.

García-Hevia, L., Casafont, I., Oliveira, J., Terán, N., Fanarraga, M. L., & Gallo, J. (2022). Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma. Bioactive Materials, 8, 153–164.

Ali Raza Ayub | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Ali Raza Ayub | Drug Delivery Systems | Best Researcher Award

Beijing Institute of Technology | Pakistan

Mr. Ali Raza Ayub is a passionate and accomplished researcher in organic and computational chemistry, with extensive experience in nanomaterials, catalysis, and environmental chemistry. He completed his M.Phil. in Organic Chemistry and M.Sc. in Chemistry from the University of Agriculture, Faisalabad, where he consistently demonstrated academic excellence and research aptitude. His academic focus has been on molecular modeling, nanochemistry, and material synthesis, combining theoretical and experimental approaches to solve real-world challenges.Currently affiliated with the Computational Lab, Department of Chemistry, University of Agriculture, Faisalabad, Mr. Ayub’s research centers on quantum-level molecular studies and photocatalytic material development. His expertise covers a broad spectrum of analytical and instrumental techniques, including UV-Vis spectroscopy, FTIR, XRD, SEM, and various chromatographic methods. His significant study, “Synthesis and Characterization of a Tertiary Composite of Cu, Mn, and g-C3N4: An Efficient Visible Light-Active Catalyst for Wastewater Treatment,” illustrates his innovative work on developing eco-friendly photocatalysts for environmental remediation.Mr. Ayub has co-authored multiple impactful publications in reputed journals, such as “Biomimetic Synthesis and Characterization of Silver Nanoparticles from Dipterygium glaucum Extract and Its Anti-Cancerous Activities,” “Synthesis of Nickel, Calcium and Magnesium Naphthalene Diimide Complexes as Supercapacitor Materials,” and “Synthesis, Combined Theoretical and Spectral Characterization of Some New 1,3,5-Triazine Compounds and Their In Vitro Biological Analysis.” His multidisciplinary work spans green chemistry, renewable energy, and bioactive compound synthesis, integrating computational modeling with experimental chemistry.He has participated in several international symposia, workshops, and conferences, contributing to collaborative scientific discussions. With 661 citations by 538 documents, 61 publications, and an h-index of 13, Mr. Ayub has established a solid academic reputation. Recipient of the Benevolent Fund Punjab Scholarship Award, he continues to advance research in sustainable chemistry, demonstrating excellence in both scientific innovation and educational contribution.

Profile: Scopus

Featured Publications

Author(s). (2025). An in-silico study of supramolecular interactions between 2,6-diisopropylphenyl derivatives of PDI and their GMP-doped composites to tune their optoelectronic response. Inorganic Chemistry Communications.

Author(s). (2025). Investigating the optoelectronic properties of Perylene Diimide-based organic molecules for high-efficiency organic solar cells. Computational and Theoretical Chemistry.

Author(s). (2025). Terpyridine–metal architectures (Zn, Cu, Fe) for energy storage: Electrochemical analysis and theoretical modeling. Journal of Electroanalytical Chemistry.

Author(s). (2025). Design of the opto-electronic characteristics of organo-solar cells using the small molecules based on Ullazine. Journal of Molecular Graphics and Modelling.

Author(s). (2025). Quantum simulation and experimental characterization of gold nanorods for DNA sensing applications. Chemical Engineering Science.

Author(s). (2025). Green synthesis of high surface area of reduced graphene oxide via Aloe vera extract: Characterization, DFT mechanistic insights, and enhanced Rhodamine B adsorption using Chitosan@EDTA@rGO composite.

Faiza Abou El-Soud | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Faiza Abou El-Soud | Formulation Science | Best Researcher Award

College of Nursing-Riyadh King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Prof. Faiza Abou El-Soud is a distinguished scholar and nursing educator whose work focuses on advancing health outcomes, improving the quality of patient care, and enriching the academic development of nursing students. With extensive expertise in nursing education, geriatric care, and psychosocial health, Professor Abou El-Soud has built a research portfolio that bridges theoretical understanding with practical application in healthcare and nursing practice. Her scholarly contributions reflect a commitment to evidence-based nursing, patient-centered care, and the empowerment of healthcare professionals through research-driven insights.Among her notable works is Nursing Students’ Perceptions toward Success and Failure Factors and their Academic Performance: A Descriptive Correlational Study, published in SYLWAN, which explores the academic determinants influencing nursing students’ success, offering valuable perspectives for educators seeking to improve nursing education outcomes. Another significant contribution, Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients with Glaucoma’s Medication, published in the Journal of Health, Medicine and Nursing, applies psychological theory to practical nursing interventions, highlighting how self-efficacy principles can enhance medication adherence among older adults suffering from glaucoma.Professor Abou El-Soud has also made important contributions to geriatric health and community nursing through her publication Quality of Life, Self-Rated Health and Social Support among Older Adult in the Saudi Community in The Malaysian Journal of Nursing, where she and her co-authors assess the complex interplay between social support, perceived health, and overall life satisfaction among elderly populations. In another influential study, The Relationship between Health-Related Quality of Life and Burden among Family Caregivers of Elderly Patients Undergoing Hemodialysis in Saudi Arabia, published in the International Journal of Nursing Research, she investigates the emotional and physical challenges faced by caregivers, offering actionable insights to enhance support systems and healthcare strategies.Her collaborative work Impact of the Intrinsic and Extrinsic Motivation Factors on the Turnover Intention among Academic Staff, published in the IOSR Journal of Nursing and Health Science, examines motivational dynamics in academic environments and their influence on faculty retention, thereby contributing to the sustainability and advancement of nursing education institutions.

Profile: Google Scholar

Featured Publications

Salama, R. A., & Abou El-Soud, F. A. (n.d.). Caregiver burden from caring for impaired elderly: A cross-sectional study in rural Lower Egypt. Italian Journal of Public Health, 9(4), 103.

AlAnnaz, W. A. A., Gouda, A. D. K., Abou El-Soud, F. A., & Alanazi, M. R. (n.d.). Obesity prevalence and its impact on maternal and neonatal outcomes among pregnant women: A retrospective cross-sectional study design. Nursing Reports, 14(2), 1236–1250.

Hussein, A. A., & El-Soud, F. A. A. (n.d.). Developing an educational intervention and a standardized clinical assessment tool to promote clinical instructors assessment skills. The Fifteenth National Conference Evidence Based Practice.

Shaqiqi, W., & Abou El-Soud, F. A. (n.d.). The mediating role of social support on the relationship between secondary traumatic stress and burnout of nurses caring for COVID-19 patients: A cross-sectional study. Applied Nursing Research, 79, 151844.

Abou El-Soud, F. A., Alhoraim, S. A., Alammar, B. A., & Alotaibi, R. S. (n.d.). Quality of life, self-rated health and social support among older adult in the Saudi community. The Malaysian Journal of Nursing, 11(3), 13–25.

Al-Shehhi, M. S. M., & El-Soud, F. A. A. (n.d.). Factors affecting quality of life in patients with end-stage renal disease on hemodialysis, Ras Al Khaimah – United Arab Emirates. Journal of Health, Medicine and Nursing, 220–238.

Abou-El-Soud, F. A., Mohamed, H. F., & Prince, J. (n.d.). The effectiveness of training workshop in changing the tutors’ knowledge and attitude towards the integration of problem-based learning into nursing curriculum. International Journal of Nursing, 5.

Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Published on by Top Pharmaceutical

Prof. Dr. Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Guangxi Medical University | China

Prof. Dr. Zefeng Lai is a leading figure in the field of pharmaceutical science, recognized for his pioneering work in nanomedicine, drug delivery, and nanotoxicology. He serves as a Professor of Pharmaceutical Science at the School of Pharmacy, Guangxi Medical University, Nanning, China, where he has made outstanding contributions to biomedical research and academic development. Having earned his BSc and PhD from the State Key Laboratory of Crystal Materials, Shandong University, and completed postdoctoral research in Drug Delivery and Biomedical Effects of Nanomaterials, Dr. Lai’s expertise integrates material chemistry with pharmacological innovation to enhance therapeutic outcomes.His research explores the mechanisms and biomedical applications of carbon-based nanodrug carriers, focusing on their transcytosis, biodistribution, and immunological effects. He has led multiple high-impact national and provincial projects, including investigations into mesona chinensis polysaccharides, fibrinolytic enzymes from marine sources, and liver-targeted nanocarriers. His work on the biotoxicity of carboxylated single-walled carbon nanotubes using zebrafish and mammalian models has been particularly influential, advancing the global understanding of nanomaterial safety in pharmaceutical formulations.Prof. Lai’s scholarly influence is reflected in his strong research metrics, with 293 citations across 279 documents, based on 19 published papers, and an impressive h-index of 10, demonstrating his consistent impact and the recognition of his contributions by the global scientific community.His groundbreaking publications demonstrate his multidisciplinary research vision. His paper Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells presents a novel nanoplatform integrating photothermal therapy and immunomodulation for non-small cell lung cancer treatment. His work Immunogenic Nano-Phthalocyanine Enables Oxygen-Economic Photodynamic Therapy for Hepatocellular Carcinoma introduces a new generation of oxygen-efficient nanotherapeutics for liver cancer. Other notable studies include Effect of Carboxylated Single-Walled Carbon Nanotubes on the Development and Morphology of Zebrafish Embryos, High Throughput CircRNA Sequencing Analysis Reveals Novel Insights into the Mechanism of Nitidine Chloride against Hepatocellular Carcinoma, and Toxic Effect of Long-Term Intravenous Injection of Carboxylated Single-Walled Carbon Nanotubes on Kidney in Rats. His research on Nitidine Chloride Induced Colorectal Cancer HT29 Cells Apoptosis Through the Cytochrome c-Mediated Mitochondrial Pathways and Long-Term Intravenous Administration of Carboxylated Single-Walled Carbon Nanotubes Induces Persistent Accumulation in the Lungs and Pulmonary Fibrosis via the NF-κB Pathway underscores his deep engagement with molecular pharmacology and nanotoxicology.

Profile: Scopus

Featured Publications

Lai, Z., Liu, Y., He, L., Wang, X., Zhang, H., & Zhao, J. (2023). Immunogenic nano-phthalocyanine enables oxygen-economic photodynamic therapy for hepatocellular carcinoma. Biomaterials, 295, 121992.

Hui Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hui Li | Drug Delivery Systems | Best Researcher Award

Woosuk University | South Korea

Dr. Hui Li is a distinguished medical scientist and otolaryngologist whose work bridges clinical medicine, translational research, and pharmaceutical innovation. He earned his Ph.D. in Translational Medicine from Seoul National University College of Medicine in Korea, where his research focused on the molecular mechanisms underlying hearing loss and radiation-induced cellular changes. Prior to his doctoral training, he completed both his Master’s and Bachelor’s degrees in Clinical Medicine from Yanbian University of Medicine in China, establishing a strong foundation in clinical diagnostics, therapeutic approaches, and patient-centered medical care.Dr. Li’s professional journey reflects an impressive progression from clinical expertise to cutting-edge biomedical research. He began his career as a medical doctor and otolaryngologist at Yanbian Yongjeong National Hospital, where he honed his clinical acumen in diagnosing and treating ear, nose, and throat disorders. His clinical excellence led him to serve as a resident and research fellow in the Department of Otolaryngology at the Affiliated Hospital of Yanbian University of Medicine, where he began integrating research into his clinical practice. He later worked as a specialist at the Yanbian National Ophthalmology & Otolaryngology Hospital, focusing on complex cases of auditory and vestibular dysfunction. These formative years in medical practice equipped him with invaluable clinical insight that continues to inform his research in translational medicine and pharmacotherapeutics.Dr. Li transitioned into academic research with his appointment as a doctoral researcher at the Department of Translational Medicine (Otolaryngology) at Seoul National University College of Medicine. There, he conducted pivotal studies on novel therapeutic delivery systems, inner ear protection mechanisms, and the molecular pathways involved in hearing impairment. His research excellence earned him postdoctoral appointments at the Cancer Research Institute within the same university, where he explored immune-modulatory effects of radiotherapy and the potential of macrophage polarization in mitigating cancer progression. Currently, he serves as a Postdoctoral Research Fellow at the Laboratory of Biopharmaceutics, Industry-Academia Cooperation Foundation, Woosuk University, Korea, where he investigates advanced drug formulations, biopharmaceutical delivery mechanisms, and the translational potential of controlled-release therapeutics.

Profile: Scopus

Featured Publications

Li, J., Wang, H., Zhang, Y., & Chen, L. (2022). Comprehensive intervention and effect of martial arts routines on children with autism. Journal of Environmental and Public Health, 2022.

Ahmad Saeed | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Mr. Ahmad Saeed | Drug Delivery Systems | Best Researcher Award

University of Education Lahore | Pakistan

Mr. Ahmad Saeed is a dedicated researcher in the field of analytical chemistry with a strong academic and research background. Currently pursuing a Bachelor of Science in Chemistry at the University of Education, Township Campus, Lahore, he has consistently demonstrated academic excellence with a notable CGPA of 3.60. Throughout his academic journey, he has actively participated in multiple research projects, including the development of biodegradable films containing biological macromolecules impregnated with curcumin for food preservation, investigation of the toxic effects of heavy metals in cosmetics on human health, and the advancement of revolutionized electrochemical sensors utilizing 2D materials as sensor electrodes. He has also contributed to innovative environmental projects, such as Clay Eco Filters, aimed at developing metal nanoparticle-impregnated clay tablets for water purification, and Ecofoil, focused on synthesizing biodegradable films for sustainable food packaging solutions.Mr. Ahmad Saeed has enriched his academic experience through hands-on laboratory work as a Graduate Research Assistant, where he worked extensively on projects involving the synthesis of nanomaterials for environmental and analytical applications. As a Teaching Assistant, he contributed to the academic development of students by assisting in atomic spectrophotometry courses, grading assignments, and providing academic guidance. He has participated in major conferences, including the International Conference on Trends and Research in Chemistry and the International Conference on Material Chemistry and Industrial Technologies, serving as both an organizer and a participant, thus gaining exposure to scholarly dialogues and academic networking.His research contributions are reflected in several scholarly publications, including Multivariate Statistical Analysis of Cosmetics Due to Potentially Toxic/Heavy Metal(loid) Contamination: Source Identification for Sustainability and Human Health Risk Assessment published in Sustainability, Structural Development of Curcumin: A Natural Product Arsenal for Diverse Therapeutic Targets – Seizing Opportunities Through Serendipity and Rational Design in the Journal of Molecular Structure, and FDA-Approved Sulfonamides-Containing Molecules: An Insightful Review on the Synthesis Strategy, Medical Indication, and Their Binding Mode under review in Chemistry and Biodiversity. These works highlight his interest in environmental sustainability, analytical chemistry, natural products, and biomedical applications.

Profile: Orcid

Featured Publications

Ahmed, M., Basheer, S., Mughram, M. H. A., Iqbal, D. N., Qamar, S., Saeed, A., Batool, R., Sanaullah, M., Raza, H., & Hussain, R. (2025). Structural development of curcumin: A natural product arsenal for diverse therapeutic targets—Seizing opportunities through serendipity and rational design. Journal of Molecular Structure.

Aslam, A. A., Ahmed, M., Mughram, M. H. A. L., Habib-ur-Rahman Mahmood, M., Basheer, S., Hussain, R., Eiman, E., Sanaullah, M., Raza, H., Saeed, A., et al. (2025). Sulfonamides as a promising scaffold in drug discovery: An insightful review on FDA-approved molecules, synthesis strategy, medical indication, and their binding mode. Chemistry and Biodiversity.

Ahmed, M., Basheer, S., Mughram, M. H. A., Iqbal, D. N., Qamar, S., Saeed, A., Batool, R., Sanaullah, M., Raza, H., & Hussain, R. (2025). Multivariate statistical analysis of cosmetics due to potentially toxic/heavy metal(loid) contamination: Source identification for sustainability and human health risk assessment. Sustainability.

Zhen Jin | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Zhen Jin | Drug Delivery Systems | Best Researcher Award

Assistant Professor at Xinxiang Medical University | China

Dr. Zhen Jin is a distinguished researcher specializing in nanomedicine, controlled drug delivery, and medical micro-nano robots. He completed doctoral and postdoctoral research at the Medical Robotics Research Institute of Chonnam National University, South Korea, before joining Xinxiang Medical College. His innovative work integrates nanodrug design, advanced therapeutic delivery systems, and cancer diagnostics. With more than 30 SCI-indexed publications, including numerous first-author papers, and four granted national invention patents, his contributions continue to influence biomedical science. His pioneering developments in imaging-guided therapy and synergistic nanocomposites highlight his commitment to advancing cancer treatment and medical robotics research globally.

Publication Profile 

Google Scholar

Education 

Dr. Zhen Jin pursued his doctoral degree at the Medical Robotics Research Institute, Chonnam National University, South Korea, where he also completed postdoctoral research. His academic journey provided a strong foundation in interdisciplinary biomedical engineering, robotics, and nanomedicine. During this period, he engaged in multiple national-level projects, honing expertise in medical micro-nano systems and cancer therapy. This rigorous academic training prepared him to advance research in nanodrugs, controlled drug delivery, and medical robotics. Following this, he transitioned to Xinxiang Medical College, where he integrated his educational background into teaching and research to foster innovation in biomedical sciences.

Experience

Dr. Zhen Jin has extensive research and academic experience, beginning with his doctoral and postdoctoral tenure in South Korea, where he contributed to significant national key projects. His expertise spans nanodrug design, micro-nano robotics, and advanced cancer diagnosis and treatment technologies. Currently, he is a faculty member at Xinxiang Medical College, where he leads cutting-edge projects funded by Henan Province. He has successfully published more than 30 SCI papers, authored key innovations, and secured national invention patents. His experience bridges academia and applied research, positioning him as a leader in biomedical nanotechnology and precision therapeutic development.

Awards and Honors

Dr. Zhen Jin has received recognition for his outstanding contributions to biomedical science, particularly in the fields of nanomedicine and cancer therapy. He has successfully participated in national research projects in South Korea and led provincial-level science and technology projects in China. His impactful research has earned him four national invention patents and numerous publications in high-impact SCI journals. His citation index reflects his growing influence in scientific communities, with an h-index of 21. These honors underscore his position as a promising and innovative researcher, making him a strong candidate for the Best Researcher Award.

Research Focus

Dr. Zhen Jin’s research focuses on nanomedicine, controlled drug delivery systems, and micro-nano robotic platforms for cancer therapy. He has developed multifunctional nanocomposites that combine therapeutic delivery with imaging capabilities for precise diagnosis and treatment. His work on DOX-HSP ananotheranostics exemplifies his focus, showcasing biocompatibility, controlled drug release, and imaging-guided multimodal therapy. By integrating photothermal and chemotherapeutic effects, his studies demonstrate enhanced anti-tumor efficacy. His pioneering approach seeks to overcome challenges of premature drug release and tumor-specific targeting, positioning his research at the forefront of personalized medicine, cancer diagnostics, and next-generation biomedical technologies.

Publication Top Notes

Human adipose–derived mesenchymal stem cell–based medical microrobot system for knee cartilage regeneration in vivo

Hybrid-actuating macrophage-based microrobots for active cancer therapy

A magnetically guided self‐rolled microrobot for targeted drug delivery, real‐time X‐Ray imaging, and microrobot retrieval

A thermo-electromagnetically actuated microrobot for the targeted transport of therapeutic agents

A magnetically actuated microscaffold containing mesenchymal stem cells for articular cartilage repair

Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy

A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor‐targeting therapy

A soft-magnet-based drug-delivery module for active locomotive intestinal capsule endoscopy using an electromagnetic actuation system

High-fidelity bioelectronic muscular actuator based on porous carboxylate bacterial cellulose membrane

Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy

Ecofriendly high-performance ionic soft actuators based on graphene-mediated cellulose acetate

Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake

Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages

Shape memory alloy–based biopsy device for active locomotive intestinal capsule endoscope

Conclusion

Dr. Zhen Jin pioneering contributions in nanomedicine, micro-nano robots, and controlled drug delivery make him a highly deserving candidate for the Best Researcher Award. His combination of innovative patents, high-impact publications, and cutting-edge theranostic development reflects exceptional promise for shaping the future of biomedical science. With continued emphasis on clinical translation and international engagement, his work is poised to leave a transformative mark on cancer diagnosis and therapy.

Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Teodora-Eliana Petcov at National University of Science and Technology POLITEHNICA Bucharest | Romania

Teodora Eliana Petcov is a driven biomedical researcher with a strong foundation in biomaterials, molecular biology, and nanotechnology. Passionate about innovation in drug delivery and regenerative medicine, she has already co-authored scientific publications in reputed journals. Her international internships, multidisciplinary skills, and involvement in EU-funded research projects underscore her commitment to advancing medical technologies. Teodora balances research excellence with volunteer leadership, contributing to both academic and community-driven initiatives. With a sharp analytical mind, hands-on lab experience, and cross-cultural exposure, she exemplifies the next generation of biomedical scientists focused on improving patient care through science and innovation.

Publication Profile 

Scopus

Education

Teodora holds a Bachelor’s degree in Medical Engineering from the Polytechnic University of Bucharest  with a focus on biomaterials and medical devices. She is currently pursuing her Master’s in Biocompatible Substances, Materials, and Systems at the National University of Science and Technology POLITEHNICA Bucharest. Her thesis explored the internalization of nano-sized devices in biological structures. She was a visiting student at “Horia Hulubei” Nuclear Institute and Floreasca Emergency Hospital. Her academic path is complemented by certifications in English  and psycho-pedagogical training, showcasing both technical expertise and educational versatility.

Experience 

Teodora has completed multiple research internships, including roles in molecular biology and materials science labs. She gained practical expertise in 3D bioprinting, SEM techniques, SolidWorks, and conducted advanced testing like DSC and DMA. She has contributed to projects at the National Institute of Physics and Nuclear Engineering, University of Campania in Italy, and worked on PNRR-funded research on bone regeneration and multiple myeloma. Additionally, she has volunteered extensively in cultural and scientific event organization, holding assistant coordinator roles in Zenezia and MED, where she honed human resources, leadership, and scientific communication skills.

Awards  

Teodora has been recognized for her academic excellence and community involvement from high school through higher education. She received top honors for her Bachelor’s thesis, was selected for the prestigious ROSE program, and presented at the “Info-Practic” National Symposium on artificial intelligence. She participated in EU-supported initiatives like ERASMUS+ “Be a Buddy, Not a Bully” and contributed to major national projects, including the ongoing PNRR-funded research on personalized bone regeneration. Her work on cutting-edge nanostructures and her leadership in volunteer networks demonstrate her well-rounded excellence and dedication to scientific and societal progress.

Research Focus 

Teodora focuses on biomedical applications of nanotechnology, with a keen interest in targeted drug delivery, biopolymeric material synthesis, and regenerative medicine. Her Master’s research and publications revolve around understanding how nanostructures interact with cellular systems to improve treatment precision in diseases like multiple myeloma. She also explores the use of 3D printed biomaterials and advanced materials characterization techniques (SEM, DSC, DMA). Her interdisciplinary research combines materials science, molecular biology, and bioengineering to design patient-specific, low-toxicity solutions, positioning her at the frontier of precision and personalized medicine.

Publication Top Notes

Title: Nanostructures: An Efficient Drug Delivery Platform for Therapy of Multiple Myeloma
Year: 2025

Conclusion

Teodora Eliana Petcov is a highly promising emerging researcher whose interdisciplinary approach, early scientific contributions, and strong practical expertise align closely with the vision of the Best Researcher Award. Her dedication to innovation in biomaterials, nanotechnology, and regenerative medicine showcases both depth and futuristic relevance.

lingcong KONG | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

lingcong KONG | Drug Discovery and Development | Best Researcher Award

Prof. lingcong KONG at Jilin Agriculture University, China.

Prof. Lingcong Kong is a dedicated veterinary scientist with a Ph.D. in Preventive Veterinary Medicine from Jilin Agricultural University 🎓. He teaches courses like Veterinary Pharmacology and Animal Toxicology 🐄 and actively mentors students in national competitions 🏆. His research focuses on antimicrobial resistance, drug resistance mechanisms, and the development of resistance inhibitors in animal pathogens 🧫🦠. He has led numerous national and provincial projects, holds multiple patents for veterinary vaccines 💉, and has published extensively in high-impact journals 📚. His work significantly enhances diagnostic tools and contributes to sustainable animal healthcare.

Publication Profile 

Scopus

Education

Prof. Lingcong Kong began his academic journey at the Inner Mongolia University for Nationalities, where he earned his Bachelor of Veterinary Medicine from September 2006 to July 2010 🐾. He then pursued advanced studies at Jilin Agricultural University, completing a Master’s degree in Basic Veterinary Medicine between 2010 and 2013 🧪. Driven by a deep passion for animal health, he continued at the same institution to earn his Ph.D. in Preventive Veterinary Medicine from September 2013 to July 2016 🔬. His education laid a strong foundation for his impactful contributions to veterinary science and research.

Experience

Prof. Lingcong Kong is a dedicated educator who teaches undergraduate courses such as “Veterinary Pharmacology”, “Veterinary Pharmacology Experiment”, and “Animal Toxicology” 🐾. At the graduate level, he lectures on “Veterinary Drug Research and Creation”, “Advanced Pharmacology”, and “Veterinary Pharmacology and Toxicology” 💊. He actively mentors students in scientific competitions, leading them to prestigious honors like the 2022 Internet+ National Award (2nd Prize) 🏅, Provincial Award (1st Prize) 🥇, and innovation contests. His guidance also earned him the Outstanding Paper Award 📝 and the Dazenong Innovation Guidance Award in 2018 🎖️, highlighting his commitment to academic excellence and innovation.

Awards

Prof. Lingcong Kong has pioneered breakthroughs in detecting and combating drug-resistant animal pathogens 🐄🧫. His innovations include PCR-ELISA rapid detection, immunomagnetic bead enrichment, and high-throughput methods for resistance gene testing 🧪. He established a pathogenic bacteria resource library 📚 and developed functional probiotics to prevent animal diarrhea 💊. By identifying 8 key resistance inhibitor targets and 6 promising lead compounds, his work has revolutionized lab diagnostics, minimized economic losses in livestock, and enhanced ecological health 🌱💼. His efforts significantly advance animal healthcare and veterinary pharmacology across Jilin Province and beyond.

Research Focus 

Prof. Lingcong Kong focuses on veterinary pharmacology, particularly targeting antimicrobial resistance and infectious diseases in animals 🐄🦠. His cutting-edge research includes discovering novel natural inhibitors like coniferaldehyde and protocatechuic aldehyde to combat Staphylococcus aureus 🧪🔬. He also explores gene transfer mechanisms, antibiotic degradation pathways, and repurposing small molecules to inhibit bacterial enzymes like KPC-2 💊. By studying agents such as C15-bacillomycin D and antibacterial proteins from Bacillus velezensis, he contributes significantly to combatting multidrug-resistant pathogens in animal and environmental health.

Publication Top Notes

  • Discovery of coniferaldehyde as an inhibitor of caseinolytic protease to combat Staphylococcus aureus infections
  • Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde
  • Acidifiers promoted antibiotic resistance gene transfer via plasmid conjugation
  • Efficient degradation of tylosin by Kurthia gibsonii TYL-A1: performance, pathway, and genomics study
  • Repurposing tavaborole to combat resistant bacterial infections through competitive inhibition of KPC-2 and metabolic disruption
  • A Novel Protein Demonstrating Antibacterial Activity Against Multidrug-Resistant Escherichia coli Purified from Bacillus velezensis CB6
  • C15-bacillomycin D produced by Bacillus amyloliquefaciens 4-9-2 suppress Fusarium graminearum infection and mycotoxin biosynthesis

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Laura Weinstein | Drug Delivery Systems | Best Researcher Award

Ms. Laura Weinstein, University of Delaware, United States

Ms. Laura Weinstein is an accomplished biomedical engineering student at the University of Delaware 🎓, set to graduate in May 2025 with a stellar GPA of 3.97. With minors in nanoscale materials and chemistry 🧪, she has led impactful research in nanoparticle drug delivery, orthotic device innovation, and immunoengineering. Her work spans labs at Delaware and Vanderbilt 🏥, earning her top honors including the Eugene du Pont Memorial Scholarship and Best Poster Awards 🏆. Passionate about translational medicine, Laura’s dedication to improving healthcare through engineering solutions marks her as a rising star in biomedical research 🌟.

Publication Profile 

Google Scholar

Education

Ms. Laura Weinstein is currently pursuing an Honors Bachelor of Science in Biomedical Engineering at the University of Delaware, with expected graduation in May 2025 📅. She maintains an outstanding GPA of 3.97 🌟 and complements her major with minors in Nanoscale Materials and Chemistry ⚗️. Her coursework spans core sciences and advanced engineering, including Introductory Biology 🧬, General Chemistry 🧪, Physics ⚛️, and Biomedical Experimental Design 📊. She has also delved into Immunoengineering, Cell Engineering 🧫, Nanomaterials, and Nanomedicine 💉. Proficient in Python and MATLAB 💻, Laura combines technical skills with scientific curiosity, preparing her for groundbreaking biomedical research 🔬.

Awards

Ms. Laura Weinstein has received numerous prestigious honors throughout her academic journey. From 2021–2025, she was awarded the esteemed Eugene du Pont Memorial Scholarship 🎓, covering full tuition, housing, meals, and book expenses. In 2024, she earned 1st place for designing a prototype to secure thoracostomy tubes 🩺. She is also a National Cyber Scholar (2022–2024) 💻 and won the Biomedical Engineering Distinguished Sophomore Award in 2023 🧬. That same year, she was recognized by the Delaware Department of Technology and Information 📡. In 2022, she placed 1st in the Ratcliffe Eco Entrepreneurship Innovation Sprint 🌱🚀

Experience

Ms. Laura Weinstein has been actively engaged in cutting-edge research at the University of Delaware’s Day Lab since January 2022 🏛️. Under the mentorship of Dr. Emily Day and PhD candidate Eric Sterin 👩‍🏫, she developed polymeric nanoparticles for biomimetic cargo delivery via cancer cell membranes 🧫. She contributed to refining purification protocols for DiD-fluorescent nanoparticles 💡 and guided fellow undergraduates in research techniques 📘. Her dedication extended beyond semesters, participating in multiple research fellowships and programs including the 2022 CBER Summer Scholars REU, 2023 Winter Fellowship, and 2024–2025 Summer/Winter Fellowships 🧪📊—highlighting her passion for biomedical innovation.

Research Focus

Ms. Laura Weinstein focuses her research in the dynamic field of biomedical nanotechnology and targeted drug delivery 🧪. Her studies explore cell biomimicry, using cancer cell membranes to improve therapeutic delivery for hematological cancers 🧫🩸. She also investigates nanoparticle purification challenges, ensuring enhanced precision in drug transport systems 🎯. Her work integrates principles of nanomedicine, immunoengineering, and materials science to develop innovative approaches in cancer treatment and diagnostics 🧬. Through her publications and lab experience, Laura contributes to advancing next-generation polymeric nanoparticle technologies—blending engineering and biology to revolutionize patient care and medical outcomes 🚀💊.

Publication Top Notes

Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes

Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution